home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.320 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

21 22 Next >

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

February 01, 2024

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

January 22, 2024

From GoodRx Holdings, Inc.

Via Business Wire

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

January 11, 2024

From GoodRx

Via Business Wire

Unveiling 7 Analyst Insights On GoodRx Holdings ↗

January 02, 2024

Via Benzinga

Where GoodRx Holdings Stands With Analysts ↗

November 10, 2023

Via Benzinga

GoodRx Holdings: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

This healthcare stock making a buzz with 160% growth

February 26, 2024

Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them.

Via MarketBeat

Topics Economy

In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings ↗

February 26, 2024

Via Benzinga

GoodRx to Participate in Upcoming Investor Conferences

February 20, 2024

From GoodRx Holdings, Inc.

Via Business Wire

Gene therapy: Why does it cost millions for a single treatment?

February 15, 2024

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.

Via MarketBeat

Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars ↗

January 10, 2024

GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million.

Via Benzinga

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

January 10, 2024

From GoodRx Holdings, Inc.

Via Business Wire

Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up ↗

January 09, 2024

Election stocks include companies at the center of national conversation and those likely to get increased government funding.

Via InvestorPlace

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

GoodRx Appoints Kelly J. Kennedy to Board of Directors

December 22, 2023

From GoodRx

Via Business Wire

GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 13, 2023

From GoodRx Holdings, Inc.

Via Business Wire

This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

November 20, 2023

U.S. stocks closed slightly higher on Friday, with the S&P 500 notching gains for the third straight week. The S&P 500 gained 2.2% last week, while the Dow Jones ended the week with a 1.9% gain.

Via Benzinga

Topics Stocks

GoodRx to Participate in the Evercore ISI HealthCONx Conference

November 16, 2023

From GoodRx Holdings, Inc.

Via Business Wire

HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Why GoodRx Holdings Stock Dived by Nearly 19% Today ↗

November 09, 2023

An unimpressive quarter featuring weak guidance led investors to hit the sell button.

Via The Motley Fool

Why Is Telemedicine Firm GoodRx's Stock Trading Lower Today? ↗

November 09, 2023

GoodRx Holdings Inc's (NASDAQ: GDRX) Q3 sales decreased 4% Y/Y to $180.0 million compared to $187.3 million, primarily due to a $10.0 million contract termination payment to a client, partially offset...

Via Benzinga

GoodRx (GDRX) Q3 2023 Earnings Call Transcript ↗

November 09, 2023

GDRX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

GoodRx Reports Third Quarter 2023 Results

November 09, 2023

From GoodRx Holdings, Inc.

Via Business Wire

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

Via Benzinga

GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

October 19, 2023

From GoodRx

Via Business Wire

GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call

October 12, 2023

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members

October 12, 2023

From GoodRx

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com